Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -49.54% is 20% below its 5-year average of -41.21%, around the middle of its 5-year range (-81.94%–-6.71%).
25.26% above its 12-month average of -66.28%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -12.15%.
RETURN ON ASSETS (ROA)
-49.54%
RETURN ON ASSETS (ROA) AVG TTM
-66.28%
RETURN ON ASSETS (ROA) AVG 3Y
-54.88%
RETURN ON ASSETS (ROA) AVG 5Y
-41.21%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+25.26%
CURRENT VS 3Y AVG
+9.73%
CURRENT VS 5Y AVG
-20.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-53.66%
vs the sector median at left
Rani Therapeutics Holdings, Inc.
Market Cap
$52.57M
Return on Assets (ROA)
-49.54%
TTM Avg
-66.28%
3Y Avg
-54.88%
5Y Avg
-41.21%
Market Cap
$52.46M
Return on Assets (ROA)
-44.77%
TTM Avg
-25.55%
3Y Avg
-81.14%
5Y Avg
-76.43%
Market Cap
$52.97M
Return on Assets (ROA)
-48.49%
TTM Avg
-50.18%
3Y Avg
-39.97%
5Y Avg
-38.29%
Market Cap
$53.04M
Return on Assets (ROA)
-32404.78%
TTM Avg
-23.59%
3Y Avg
-11.80%
5Y Avg
-9.44%
Market Cap
$53.24M
Return on Assets (ROA)
-34.52%
TTM Avg
-27.74%
3Y Avg
-32.72%
5Y Avg
-28.49%
Market Cap
$52.05M
Return on Assets (ROA)
5.76%
TTM Avg
13.86%
3Y Avg
7.25%
5Y Avg
29.75%
Market Cap
$51.80M
Return on Assets (ROA)
N/A
TTM Avg
-109.69%
3Y Avg
-346.56%
5Y Avg
-277.44%
Market Cap
$53.62M
Return on Assets (ROA)
-54.01%
TTM Avg
-81.00%
3Y Avg
-93.15%
5Y Avg
-65.68%
Market Cap
$51.42M
Return on Assets (ROA)
-127.67%
TTM Avg
-99.17%
3Y Avg
-76.90%
5Y Avg
-71.83%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | $52.57M | -49.54% | -66.28% | -54.88% | -41.21% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -44.77% | -25.55% | -81.14% | -76.43% |
| Aldeyra The (ALDX)vs › | $52.97M | -48.49% | -50.18% | -39.97% | -38.29% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.04M | -32404.78% | -23.59% | -11.80% | -9.44% |
| ImageneBio Inc (IMA)vs › | $53.24M | -34.52% | -27.74% | -32.72% | -28.49% |
| biote Corp. (BTMD)vs › | $52.05M | 5.76% | 13.86% | 7.25% | 29.75% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.80M | N/A | -109.69% | -346.56% | -277.44% |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | -54.01% | -81.00% | -93.15% | -65.68% |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -127.67% | -99.17% | -76.90% | -71.83% |
| Clene Inc. (CLNN)vs › | $50.83M | -171.51% | -144.24% | -112.57% | -82.33% |
ROA
-49.5%
ROE
-76.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -50.62% |
| 2024-12-31 | -81.94% |
| 2023-12-31 | -58.65% |
| 2022-12-31 | -28.32% |
| 2021-12-31 | -6.71% |
| 2020-12-31 | -21.03% |
| 2019-12-31 | -115.53% |
